We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Addus HomeCare Corporation (ADUS) Hit a 52 Week High, Can the Run Continue?
Read MoreHide Full Article
A strong stock as of late has been Addus HomeCare (ADUS - Free Report) . Shares have been marching higher, with the stock up 11% over the past month. The stock hit a new 52-week high of $131.59 in the previous session. Addus HomeCare has gained 18.1% since the start of the year compared to the 8.3% gain for the Zacks Medical sector and the 31.8% return for the Zacks Medical - Outpatient and Home Healthcare industry.
What's Driving the Outperformance?
The stock has a great record of positive earnings surprises, having beaten the Zacks Consensus Estimate in each of the last four quarters. In its last earnings report on November 3, 2026, Addus HomeCare reported EPS of $1.83 versus consensus estimate of $1.78.
For the current fiscal year, Addus HomeCare is expected to post earnings of $7.07 per share on $1.52 in revenues. This represents a 13.48% change in EPS on a 7.03% change in revenues. For the next fiscal year, the company is expected to earn $7.57 per share on $1.6 in revenues. This represents a year-over-year change of 7.09% and 4.87%, respectively.
Valuation Metrics
Though Addus HomeCare has recently hit a 52-week high, what is next for Addus HomeCare? A key aspect of this question is taking a look at valuation metrics in order to determine if the company is due for a pullback from this level.
On this front, we can look at the Zacks Style Scores, as these give investors a variety of ways to comb through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. Investors should consider the style scores a valuable tool that can help you to pick the most appropriate Zacks Rank stocks based on their individual investment style.
Addus HomeCare has a Value Score of A. The stock's Growth and Momentum Scores are B and B, respectively, giving the company a VGM Score of A.
In terms of its value breakdown, the stock currently trades at 17.9X current fiscal year EPS estimates, which is not in-line with the peer industry average of 21.8X. On a trailing cash flow basis, the stock currently trades at 19.5X versus its peer group's average of 16.8X. Additionally, the stock has a PEG ratio of 1.51. This is good enough to put the company in the top echelon of all stocks we cover from a value perspective, making Addus HomeCare an interesting choice for value investors.
Zacks Rank
We also need to consider the stock's Zacks Rank, as this is even more important than the company's VGM Score. Fortunately, Addus HomeCare currently has a Zacks Rank of #2 (Buy) thanks to favorable earnings estimate revisions from covering analysts.
Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Addus HomeCare meets the list of requirements. Thus, it seems as though Addus HomeCare shares could have potential in the weeks and months to come.
View the Zacks #1 Rank List
Image: Bigstock
Addus HomeCare Corporation (ADUS) Hit a 52 Week High, Can the Run Continue?
A strong stock as of late has been Addus HomeCare (ADUS - Free Report) . Shares have been marching higher, with the stock up 11% over the past month. The stock hit a new 52-week high of $131.59 in the previous session. Addus HomeCare has gained 18.1% since the start of the year compared to the 8.3% gain for the Zacks Medical sector and the 31.8% return for the Zacks Medical - Outpatient and Home Healthcare industry.
What's Driving the Outperformance?
The stock has a great record of positive earnings surprises, having beaten the Zacks Consensus Estimate in each of the last four quarters. In its last earnings report on November 3, 2026, Addus HomeCare reported EPS of $1.83 versus consensus estimate of $1.78.
For the current fiscal year, Addus HomeCare is expected to post earnings of $7.07 per share on $1.52 in revenues. This represents a 13.48% change in EPS on a 7.03% change in revenues. For the next fiscal year, the company is expected to earn $7.57 per share on $1.6 in revenues. This represents a year-over-year change of 7.09% and 4.87%, respectively.
Valuation Metrics
Though Addus HomeCare has recently hit a 52-week high, what is next for Addus HomeCare? A key aspect of this question is taking a look at valuation metrics in order to determine if the company is due for a pullback from this level.
On this front, we can look at the Zacks Style Scores, as these give investors a variety of ways to comb through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. Investors should consider the style scores a valuable tool that can help you to pick the most appropriate Zacks Rank stocks based on their individual investment style.
Addus HomeCare has a Value Score of A. The stock's Growth and Momentum Scores are B and B, respectively, giving the company a VGM Score of A.
In terms of its value breakdown, the stock currently trades at 17.9X current fiscal year EPS estimates, which is not in-line with the peer industry average of 21.8X. On a trailing cash flow basis, the stock currently trades at 19.5X versus its peer group's average of 16.8X. Additionally, the stock has a PEG ratio of 1.51. This is good enough to put the company in the top echelon of all stocks we cover from a value perspective, making Addus HomeCare an interesting choice for value investors.
Zacks Rank
We also need to consider the stock's Zacks Rank, as this is even more important than the company's VGM Score. Fortunately, Addus HomeCare currently has a Zacks Rank of #2 (Buy) thanks to favorable earnings estimate revisions from covering analysts.
Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Addus HomeCare meets the list of requirements. Thus, it seems as though Addus HomeCare shares could have potential in the weeks and months to come.